Long-term outcomes of intraoperative triamcinolone injection versus postoperative oral prednisolone in congenital cataract surgery
2024

Long-term outcomes of triamcinolone vs. prednisolone in congenital cataract surgery

Sample size: 26 publication Evidence: moderate

Author Information

Author(s): Bruna Vieira Ventura, Mariana Zaira Ribeiro, Nayara Rayanne Bezerra Caldas, Larissa Ventura, Polyana Marinho, Rodrigo Pessoa Cavalcanti Lira, Camilla Silva da Rocha, Marcelo Carvalho Ventura

Primary Institution: Fundação Altino Ventura

Hypothesis

Is intraoperative triamcinolone injection as effective as postoperative oral prednisolone in managing inflammation after congenital cataract surgery?

Conclusion

The long-term ocular findings of children who received triamcinolone during surgery were similar to those who used oral prednisolone, suggesting triamcinolone may be a suitable alternative.

Supporting Evidence

  • Both treatment groups had similar ocular findings after a mean of 8 years.
  • None of the eyes developed glaucoma or required reoperation.
  • All eyes had a centered intraocular lens at the last visit.

Takeaway

This study found that using a special medicine during cataract surgery for kids works just as well as taking medicine afterward, making it easier for families.

Methodology

This was a prospective cohort study reviewing medical records and conducting ophthalmologic exams on children who had congenital cataract surgery.

Limitations

The study had a small sample size and challenges in patient follow-up.

Participant Demographics

Children who underwent congenital cataract surgery before the age of two, with a mean age at surgery of approximately 10.9 months.

Statistical Information

P-Value

p=0.82

Digital Object Identifier (DOI)

10.5935/0004-2749.2021-0514

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication